Cargando…

Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors

PURPOSE: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors, and their biological behavior is not well known. We studied the presence and potential functional roles of somatostatin receptors (sst1-5), focusing particularly on the truncated variants (sst5TMD4, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampedro-Núñez, Miguel, Luque, Raúl M., Ramos-Levi, Ana M., Gahete, Manuel D., Serrano-Somavilla, Ana, Villa-Osaba, Alicia, Adrados, Magdalena, Ibáñez-Costa, Alejandro, Martín-Pérez, Elena, Culler, Michael D., Marazuela, Mónica, Castaño, Justo P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872735/
https://www.ncbi.nlm.nih.gov/pubmed/26673010
http://dx.doi.org/10.18632/oncotarget.6565
_version_ 1782432775516717056
author Sampedro-Núñez, Miguel
Luque, Raúl M.
Ramos-Levi, Ana M.
Gahete, Manuel D.
Serrano-Somavilla, Ana
Villa-Osaba, Alicia
Adrados, Magdalena
Ibáñez-Costa, Alejandro
Martín-Pérez, Elena
Culler, Michael D.
Marazuela, Mónica
Castaño, Justo P.
author_facet Sampedro-Núñez, Miguel
Luque, Raúl M.
Ramos-Levi, Ana M.
Gahete, Manuel D.
Serrano-Somavilla, Ana
Villa-Osaba, Alicia
Adrados, Magdalena
Ibáñez-Costa, Alejandro
Martín-Pérez, Elena
Culler, Michael D.
Marazuela, Mónica
Castaño, Justo P.
author_sort Sampedro-Núñez, Miguel
collection PubMed
description PURPOSE: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors, and their biological behavior is not well known. We studied the presence and potential functional roles of somatostatin receptors (sst1-5), focusing particularly on the truncated variants (sst5TMD4, sst5TMD5) and on their relationships with the angiogenic system (Ang/Tie-2 and VEGF) in human GEP-NETs. EXPERIMENTAL DESIGN: We evaluated 42 tumor tissue samples (26 primary/16 metastatic) from 26 patients with GEP-NETs, and 30 non-tumoral tissues (26 from adjacent non-tumor regions and 4 from normal controls) from a single center. Expression of sst1-5, sst5TMD4, sst5TMD5, Ang1-2, Tie-2 and VEGF was analyzed using real-time qPCR, immunofluorescence and immunohistochemistry. Expression levels were associated with tumor characteristics and clinical outcomes. Functional role of sst5TMD4 was analyzed in GEP-NET cell lines. RESULTS: sst1 exhibited the highest expression in GEP-NET, whilst sst2 was the most frequently observed sst-subtype (90.2%). Expression levels of sst1, sst2, sst3, sst5TMD4, and sst5TMD5 were significantly higher in tumor tissues compared to their adjacent non-tumoral tissue. Lymph-node metastases expressed higher levels of sst5TMD4 than in its corresponding primary tumor tissue. sst5TMD4 was also significantly higher in intestinal tumor tissues from patients with residual disease of intestinal origin compared to those with non-residual disease. Functional assays demonstrated that the presence of sst5TMD4 was associated to enhanced malignant features in GEP-NET cells. Angiogenic markers correlated positively with sst5TMD4, which was confirmed by immunohistochemical/fluorescence studies. CONCLUSIONS: sst5TMD4 is overexpressed in GEP-NETs and is associated to enhanced aggressiveness, suggesting its potential value as biomarker and target in GEP-NETs.
format Online
Article
Text
id pubmed-4872735
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-48727352016-05-25 Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors Sampedro-Núñez, Miguel Luque, Raúl M. Ramos-Levi, Ana M. Gahete, Manuel D. Serrano-Somavilla, Ana Villa-Osaba, Alicia Adrados, Magdalena Ibáñez-Costa, Alejandro Martín-Pérez, Elena Culler, Michael D. Marazuela, Mónica Castaño, Justo P. Oncotarget Research Paper PURPOSE: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous tumors, and their biological behavior is not well known. We studied the presence and potential functional roles of somatostatin receptors (sst1-5), focusing particularly on the truncated variants (sst5TMD4, sst5TMD5) and on their relationships with the angiogenic system (Ang/Tie-2 and VEGF) in human GEP-NETs. EXPERIMENTAL DESIGN: We evaluated 42 tumor tissue samples (26 primary/16 metastatic) from 26 patients with GEP-NETs, and 30 non-tumoral tissues (26 from adjacent non-tumor regions and 4 from normal controls) from a single center. Expression of sst1-5, sst5TMD4, sst5TMD5, Ang1-2, Tie-2 and VEGF was analyzed using real-time qPCR, immunofluorescence and immunohistochemistry. Expression levels were associated with tumor characteristics and clinical outcomes. Functional role of sst5TMD4 was analyzed in GEP-NET cell lines. RESULTS: sst1 exhibited the highest expression in GEP-NET, whilst sst2 was the most frequently observed sst-subtype (90.2%). Expression levels of sst1, sst2, sst3, sst5TMD4, and sst5TMD5 were significantly higher in tumor tissues compared to their adjacent non-tumoral tissue. Lymph-node metastases expressed higher levels of sst5TMD4 than in its corresponding primary tumor tissue. sst5TMD4 was also significantly higher in intestinal tumor tissues from patients with residual disease of intestinal origin compared to those with non-residual disease. Functional assays demonstrated that the presence of sst5TMD4 was associated to enhanced malignant features in GEP-NET cells. Angiogenic markers correlated positively with sst5TMD4, which was confirmed by immunohistochemical/fluorescence studies. CONCLUSIONS: sst5TMD4 is overexpressed in GEP-NETs and is associated to enhanced aggressiveness, suggesting its potential value as biomarker and target in GEP-NETs. Impact Journals LLC 2015-12-11 /pmc/articles/PMC4872735/ /pubmed/26673010 http://dx.doi.org/10.18632/oncotarget.6565 Text en Copyright: © 2016 Sampedro-Núñez et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Sampedro-Núñez, Miguel
Luque, Raúl M.
Ramos-Levi, Ana M.
Gahete, Manuel D.
Serrano-Somavilla, Ana
Villa-Osaba, Alicia
Adrados, Magdalena
Ibáñez-Costa, Alejandro
Martín-Pérez, Elena
Culler, Michael D.
Marazuela, Mónica
Castaño, Justo P.
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
title Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
title_full Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
title_fullStr Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
title_full_unstemmed Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
title_short Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
title_sort presence of sst5tmd4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872735/
https://www.ncbi.nlm.nih.gov/pubmed/26673010
http://dx.doi.org/10.18632/oncotarget.6565
work_keys_str_mv AT sampedronunezmiguel presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT luqueraulm presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT ramoslevianam presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT gahetemanueld presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT serranosomavillaana presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT villaosabaalicia presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT adradosmagdalena presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT ibanezcostaalejandro presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT martinperezelena presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT cullermichaeld presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT marazuelamonica presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors
AT castanojustop presenceofsst5tmd4atruncatedsplicevariantofthesomatostatinreceptorsubtype5isassociatedtofeaturesofincreasedaggressivenessinpancreaticneuroendocrinetumors